SABSW
USDSAB Biotherapeutics Inc. Warrant
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$0.048
Hoch
$0.039
Tief
$0.028
Volumen
0.01M
Unternehmensfundamentaldaten
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Börse
NCM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
Ähnliche Aktien
BTBD
BT Brands Inc.
OVLY
Oak Valley Bancorp (CA)
PML
Pimco Municipal Income Fund II Common Shares of Beneficial Interest
REGCO
Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock
GBBKW
Global Blockchain Acquisition Corp. Warrant
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.